Last checked at 11 Jun 2021 11:13
Ap19
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 08 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,869,085 | 1.45% | 231,116 | 0.18% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 94,581 | 0.07% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,947,544 | 1.51% | 331,797 | 0.26% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 11 | 253.1281 USD |
Purchase | 18 | 254.1106 USD |
Purchase | 41 | 254.1400 USD |
Purchase | 44 | 254.1500 USD |
Purchase | 53 | 254.0077 USD |
Purchase | 96 | 253.7760 USD |
Purchase | 99 | 253.1100 USD |
Purchase | 100 | 253.3300 USD |
Purchase | 100 | 253.9900 USD |
Purchase | 171 | 254.1014 USD |
Purchase | 192 | 253.6628 USD |
Purchase | 342 | 253.3595 USD |
Purchase | 520 | 253.1646 USD |
Purchase | 543 | 253.8637 USD |
Purchase | 600 | 253.4899 USD |
Purchase | 749 | 253.0544 USD |
Purchase | 1,000 | 253.9045 USD |
Purchase | 1,043 | 254.5282 USD |
Purchase | 1,100 | 253.8272 USD |
Purchase | 1,159 | 253.7455 USD |
Purchase | 1,296 | 253.9477 USD |
Purchase | 1,500 | 254.3833 USD |
Purchase | 1,544 | 253.5435 USD |
Purchase | 1,802 | 253.7099 USD |
Purchase | 2,486 | 253.5518 USD |
Purchase | 2,529 | 253.5217 USD |
Purchase | 3,375 | 253.4864 USD |
Purchase | 3,616 | 253.3372 USD |
Purchase | 4,156 | 254.0515 USD |
Purchase | 5,373 | 254.1733 USD |
Purchase | 12,423 | 253.9115 USD |
Purchase | 12,714 | 254.5700 USD |
Purchase | 13,796 | 254.5928 USD |
Purchase | 26,166 | 253.7006 USD |
Purchase | 33,457 | 253.4957 USD |
Sale | 1 | 254.4600 USD |
Sale | 4 | 254.3675 USD |
Sale | 5 | 254.0100 USD |
Sale | 7 | 254.0371 USD |
Sale | 28 | 253.9850 USD |
Sale | 64 | 253.7760 USD |
Sale | 141 | 253.0076 USD |
Sale | 467 | 253.6607 USD |
Sale | 765 | 253.3977 USD |
Sale | 1,043 | 254.5282 USD |
Sale | 1,400 | 254.4207 USD |
Sale | 1,721 | 253.6203 USD |
Sale | 2,446 | 253.5628 USD |
Sale | 4,624 | 253.5133 USD |
Sale | 4,928 | 253.3503 USD |
Sale | 5,006 | 254.2148 USD |
Sale | 9,594 | 254.5700 USD |
Sale | 13,796 | 254.5928 USD |
Sale | 35,043 | 253.4847 USD |
Sale | 50,000 | 253.7996 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 11 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price |
| date |
|
| to which the option |
|
|
|
|
| or derivative |
|
|
|
|
| relates |
|
|
|
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210611005203/en/
Copyright Business Wire 2021